Crossmark

Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway

Crossref DOI link: https://doi.org/10.1186/s13287-019-1321-y

Published Online: 2019-07-19

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Xuenan

Li, Zheng

Liu, Hao

Zhu, Yuan

Xia, Dandan

Wang, Siyi

Gu, Ranli

Wu, Weiliang

Zhang, Ping

Liu, Yunsong https://orcid.org/0000-0001-8364-1898
Zhou, Yongsheng
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2016YFC1102900)

National Natural Science Foundation of China (81771039)

Interdisciplinary Medicine Seed Fund of Peking University (BMU2018ME005)

Beijing Nova Program (Z181100006218037)
License Information

Text and Data Mining valid from 2019-07-19

Version of Record valid from 2019-07-19
More Information

Article History

Received: 8 April 2019

Revised: 9 June 2019

Accepted: 30 June 2019

First Online: 19 July 2019

Ethics approval and consent to participate

: This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the Peking University Health Science Center (approval no. LA2014233). All surgeries were performed under anesthesia, and all efforts were made to minimize animal suffering.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below